[Recalled] IMMULITE ¿ 2000/IMMULITE ¿ 2000 XPi BR-MA (CA15-3) — Concentrations for the level of biotin that does not interfere is not currently… | FDA 2018-01-02
This is an official product-safety recall record. Below are the verified details from the issuing authority, in plain language.
Recall details
| Product | IMMULITE ¿ 2000/IMMULITE ¿ 2000 XPi BR-MA (CA15-3) |
|---|---|
| Brand / manufacturer | Siemens Healthcare Diagnostics, Inc. |
| Category | device |
| Issuing authority | FDA_DEVICE |
| Reference | Z-1691-2018 |
| Country of notice | United States |
| Risk level | Class II |
| Hazard type | recall |
| Notice date | 02 January 2018 |
Why it was recalled
According to the FDA_DEVICE notice, the identified hazard is: Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA, Folic Acid, Gastrin, OM-MA (CA125), Thyroglobulin, and Vitamin B12, and these assays are susceptible to interference from biotin.
This Class II recall concerns device products distributed in United States and was recorded by FDA_DEVICE. Recalls in this category are published so that owners, retailers, and importers can identify affected units and act quickly.
What to do if you own this product
Check whether your unit is affected and follow the authority's guidance before further use.
Read the full official notice →
Related recalls from Siemens Healthcare Diagnostics, Inc.
This page indexes a public government recall notice for reference. We do not sell or verify this product; always confirm the current status on the authority's official site.